Novel Approaches Beyond Fusion in Lumbar Degenerative Disease
Abstract
Background: Degenerative lumbar spine disease management has evolved beyond decompression and fusion to include minimally invasive endoscopic surgery, motion-preserving technologies, intradiscal biologics, annular repair, and vertebrogenic denervation, aligned to specific pain generators.
Objective: To synthesize 2020–2025 evidence on contemporary options beyond fusion and present a mechanism-based patient selection algorithm for Indian orthopaedic practitioners.
Methods: A targeted narrative review examined minimally invasive/endoscopic decompression, lateral/oblique interbody fusion with navigation/robotics, motion preservation (TDR), intradiscal biologics including nucleus pulposus allograft, annular closure devices, basivertebral nerve ablation, and adjacent segment disease (ASD) prevention strategies.
Results: Endoscopic discectomy matches microdiscectomy outcomes with faster recovery; LLIF/OLIF restore height and lordosis via muscle-sparing corridors; navigation/robotics enhance accuracy and efficiency; TDR preserves motion with durable mid-term outcomes in selected single-level disease; nucleus pulposus allograft provides sustained benefits in early–moderate discogenic pain; annular closure reduces reherniation in large-defect scenarios; basivertebral nerve ablation offers durable relief for vertebrogenic pain; and alignment-centric constructs mitigate ASD risk.
Conclusions: Mechanism-based, least-invasive effective algorithms can optimize outcomes and reduce morbidity in degenerative lumbar disease. Long-term comparative effectiveness, refined selection tools, cost-effectiveness analyses, and technology accessibility remain priorities for broader adoption in Indian practice settings.
Keywords: Degenerative lumbar spine disease, minimally invasive spine surgery, motion preservation, endoscopic discectomy, intradiscal biologics, basivertebral nerve ablation, India
Introduction
Degenerative lumbar spine disease is a major cause of disability in India, affecting working-age populations and placing substantial burden on healthcare systems and productivity. The condition encompasses disc degeneration, facet arthropathy, stenosis, and spondylolisthesis, with pain phenotypes that include radiculopathy, discogenic pain, and vertebrogenic pain mechanisms.
Historically, surgical treatment centered on decompression and fusion, which, while effective, is associated with muscle injury, motion loss, prolonged recovery, and risk of adjacent segment degeneration affecting 15–30% of patients within 5–10 years. Over the past five years, international evidence has matured for minimally invasive endoscopic decompression, lateral and oblique interbody fusion with navigation or robotics, motion-preserving total disc replacement (TDR), intradiscal biologics including nucleus pulposus allograft, annular closure devices, and basivertebral nerve ablation, offering a portfolio of mechanism-aligned alternatives suitable for Indian surgical practice where feasible.
This review synthesizes contemporary evidence (2020–2025) to equip Indian orthopaedic surgeons with knowledge of evidence-based options beyond fusion, recognizing regional resource constraints, patient preferences, and clinical contexts in India.
Methods
A narrative review was conducted of peer-reviewed literature and clinical guidance published 2020–2025 across endoscopic decompression, lateral/oblique interbody fusion with navigation/robotics, TDR, intradiscal biologics and nucleus pulposus allograft, annular closure, basivertebral nerve ablation, and ASD prevention. Priority was given to systematic reviews, randomized controlled trials (RCTs), prospective cohorts, and contemporary clinical guidance from major international societies and centers relevant to degenerative lumbar disease and feasible implementation in Indian healthcare environments. Representative sources included Spine, Journal of Bone & Joint Surgery, Asian Spine Journal, Brain & Spine, Neurospine, and institutional clinical resources, with all citations from 2020 onward to reflect current devices, techniques, selection criteria, and outcomes.
Results
Minimally Invasive and Endoscopic Decompression
Transforaminal endoscopic lumbar discectomy (TELD) has become increasingly popular in Asia, achieving pain and functional outcomes comparable to microdiscectomy with significant advantages in perioperative morbidity, shorter hospitalization (1–2 days vs. 2–3 days), and faster return to work in appropriately selected contained herniations. Contemporary case series from Asian centers and multinational reviews confirm that endoscopic approaches are safe and effective in experienced hands, with a recognizable learning curve of approximately 50–100 cases. Indian centers with trained endoscopic programs can benefit from reduced tissue trauma, blood loss, and length of stay while maintaining outcomes comparable to open microdiscectomy, making this a viable option where expertise exists.
Lateral and Oblique Interbody Approaches with Navigation/Robotics
Oblique lateral interbody fusion (OLIF) and lateral lumbar interbody fusion (LLIF) have gained traction globally for restoring disc height and segmental lordosis through retroperitoneal corridors that avoid posterior muscle dissection, reducing approach-related morbidity. Comparative series show that OLIF and ALIF achieve similar decompression and alignment correction, with OLIF particularly attractive for single-position workflows when combined with percutaneous pedicle screw fixation. Navigation-guided and robot-assisted single-position prone LLIF further enhance accuracy, reduce intraoperative radiation exposure, and improve operative efficiency in multilevel constructs—advantages that can benefit Indian centers aiming to optimize safety and efficiency in complex degenerative cases.
Motion Preservation: Lumbar Total Disc Replacement
Modern lumbar total disc replacement produces sustained reductions in pain and disability with preservation of index-level motion, with systematic reviews and mid-term cohorts demonstrating superiority or non-inferiority compared with fusion in appropriately selected single-level degenerative disc disease with intact facets and no significant deformity. While TDR adoption in India has been gradual due to cost and regulatory considerations, available evidence supports its role for active patients with single-level DDD and preserved facets, where insurance or patient resources permit. North American and European coverage recommendations have refined indications and contraindications, which can inform Indian practice guidelines as technology becomes more accessible.
Intradiscal Biologics and Nucleus Pulposus Allograft
Intradiscal strategies including mesenchymal stromal cells (MSCs), platelet-rich plasma (PRP), and nucleus pulposus allograft represent a paradigm shift toward biologic and regenerative approaches for early–moderate discogenic pain. Nucleus pulposus allograft (VIA Disc NP) offers a cell-free, off-the-shelf option with prospective and real-world data showing sustained 24-month improvements in pain and function, with generalizability across Pfirrmann grades and Modic strata. For Indian practitioners, such cell-free biologics may offer a more accessible pathway to regenerative treatment compared with cellular products, pending regulatory approvals and cost considerations.
Annular Closure After Discectomy
A pivotal randomized trial and subsequent meta-analysis demonstrated that bone-anchored annular closure devices significantly reduce symptomatic reherniation and reoperation through five years in patients with large annular defects (>6 mm) after discectomy, with preserved disc height. This approach directly addresses a high-risk recurrence scenario and can be incorporated into Indian surgical practice when intraoperative defect size and disc height criteria are met, offering an elegant prevention strategy that avoids revision surgery.
Basivertebral Nerve Ablation for Vertebrogenic Pain
Basivertebral nerve ablation (Intracept procedure) has emerged as a validated option for chronic axial low back pain with Modic type 1 or 2 endplate changes, demonstrating durable improvements in pain and disability through five years across RCTs and pooled analyses. This implant-free, minimally invasive denervation technique preserves future surgical options and represents an important addition to the therapeutic armamentarium for patients with refractory vertebrogenic pain who have exhausted conservative management. Regulatory approval and technology access in India will determine feasibility for Indian patients.
Adjacent Segment Disease Prevention
Recent guidance emphasizes limiting fusion length, restoring pelvic incidence–lumbar lordosis (PI–LL) congruence, optimizing bone health and metabolic parameters, and strategically using motion preservation to mitigate adjacent segment degeneration burden. These principles are universally applicable and should be incorporated into surgical planning for all degenerative lumbar cases, regardless of the primary intervention chosen.
Discussion
The 2020–2025 evidence base supports a broadened, mechanism-based approach to degenerative lumbar disease that extends well beyond decompression and fusion. For Indian orthopaedic surgeons, adopting a selective, evidence-informed portfolio aligned to pain generators and structural pathology—endoscopic decompression for radiculopathy, intradiscal options for discogenic pain, basivertebral ablation for vertebrogenic pain, and MIS fusion or motion preservation for instability or deformity—can optimize outcomes while reducing morbidity and recovery time.
Key challenges in implementing these advances in Indian practice include:
- Technology and training availability: Endoscopic decompression, navigation/robotics, and some biologics require specialized equipment and training that may not be accessible in all Indian centers.
- Cost and accessibility: Motion-preserving devices, advanced biologics, and navigation systems carry significant costs that may limit access for many Indian patients; however, cost-effective alternatives and phased adoption pathways warrant exploration.
- Regulatory frameworks: Some advanced biologics and devices require regulatory approvals in India; practitioners should stay updated on device clearances and permissible applications.
- Evidence gaps: Long-term head-to-head comparisons of novel techniques in Indian populations, health-economic analyses, and locally derived selection algorithms remain priorities to guide guideline development and coverage decisions.
Clinical Algorithm for Indian Practice
Step 1: Identify the dominant pain generator through history, examination, MRI (disc pathology, facet status, canal/foramen anatomy, Modic changes), and standing alignment (PI–LL).
Step 2: For contained soft herniation radiculopathy without instability → Endoscopic TELD where expertise available; otherwise, standard microdiscectomy.
Step 3: For spinal stenosis without instability after failed conservative care → Targeted decompression; consider interspinous device in extension-predominant symptoms if suitable anatomy.
Step 4: For axial discogenic pain with preserved disc height/containment → Explore intradiscal biologic or nucleus pulposus allograft options when available.
Step 5: For vertebrogenic pain (Modic 1/2) refractory to conservative care → Basivertebral nerve ablation when regulatory approval and technology access permit.
Step 6: For single-level DDD with intact facets and no deformity in active patients → Consider TDR if cost and insurance permit; otherwise, MIS TLIF/PLIF.
Step 7: For instability, deformity, or multilevel disease → MIS LLIF/OLIF/TLIF with percutaneous fixation using navigation where available to optimize alignment and accuracy.
Step 8: Across all cases, prioritize restoring PI–LL alignment, limit fusion length, and use motion preservation where appropriate to mitigate ASD burden.
Conclusions
Degenerative lumbar spine disease in India can be managed using mechanism-based, least-invasive-effective strategies that extend well beyond decompression and fusion. Endoscopic decompression, intradiscal biologics, motion preservation, annular closure, and vertebrogenic ablation offer evidence-supported alternatives with varying feasibility and accessibility across Indian centers.
Priorities for advancing Indian spine surgery include:
- Building capacity and training in minimally invasive endoscopic and navigation-guided techniques.
- Developing health-economic models to support cost-effective adoption and insurance coverage of advanced technologies.
- Establishing local guidelines and algorithms adapted to Indian practice contexts, patient populations, and healthcare systems.
- Strengthening research and registries to generate locally relevant evidence on outcomes, safety, and cost-effectiveness.
- Facilitating regulatory approvals for promising biologics and devices to expand options for Indian patients.
By integrating contemporary evidence with pragmatic adaptation to Indian healthcare environments, spine surgeons can optimize patient outcomes while reducing morbidity and recovery burden in this growing patient population.
Acknowledgments
None.
Conflict of Interest
The authors report no conflicts of interest.
Funding
No external funding was received for this manuscript.
References (2020–2025 only)
- Donnally CJ III, et al. Lumbar Degenerative Disk Disease. StatPearls; 2023.
- Advances and challenges in minimally invasive spine surgery. 2024.
- Cleveland Clinic. Minimally Invasive Spine Surgery (institutional guidance). 2025.
- Ahn Y, et al. Transforaminal Endoscopic Lumbar Discectomy. 2021.
- TELD case application and technique pearls. J Minim Invasive Spine Surg Tech. 2024.
- Chung HW, et al. Comparison of OLIF and ALIF surgical outcomes. J Clin Neurosci. 2021.
- Liu JC, et al. Navigation and robotic single-position prone LLIF. 2024.
- Lee YS, et al. Navigation-guided/robot-assisted spinal surgery. Neurospine. 2024.
- Sundaram PPM, et al. Does robotic spine surgery add value to outcomes and efficiency? Medicina. 2024.
- Current state and future perspectives of spinal navigation and robotics. Brain & Spine. 2025.
- Sono T, et al. Regenerative therapies for lumbar degenerative disc disease. Front Bioeng Biotechnol. 2024.
- Li Y, et al. Biologics and regenerative medicine in intervertebral disc disease. 2021.
- Block JE, et al. Nucleus pulposus allograft (VIA Disc NP) prospective outcomes. Pain Physician. 2024.
- Costandi S, et al. Durability of supplemental nucleus pulposus allograft. J Pain Res. 2025.
- Supplemental NP allograft—Medicare cohort analysis. 2025.
- Wen DJ, et al. Lumbar total disc replacement for DDD—systematic review. Spine. 2024.
- Clinical outcomes after 1–2-level lumbar TDR—contemporary cohort. 2024.
- Long-term outcomes of total lumbar disc prosthesis—synthesis. Brain & Spine. 2025.
- NASS coverage recommendations—lumbar artificial disc replacement (draft). 2024.
- Efficacy and safety of interspinous process devices—systematic review/meta-analysis. 2024.
- Efficacy and outcomes for different lumbar interspinous devices—perspective. Surg Neurol Int. 2024.
- Thomé C, et al. Annular closure device to prevent recurrent herniation—randomized trial. JAMA Netw Open. 2021.
- Wang Y, et al. Annulus fibrosus repair after lumbar discectomy—meta-analysis. Spine. 2023.
- Annular closure devices—review and selection. Neurospine. 2022.
- Basivertebral nerve ablation for vertebrogenic low back pain—review/pooled outcomes. 2025.
- Cleveland Clinic. Intracept procedure and vertebrogenic pain overview. 2025.
- 12-month RCT outcomes for BVN ablation—ODI and VAS improvements. Reg Anesth Pain Med. 2021.
- Five-year pooled/long-term outcomes in BVN programs. 2024–2025.
- How to prevent adjacent segment problems in degenerative lumbar fusion. Brain & Spine. 2025.
- Risk factors for early-onset ASD after lumbar fusion. Sci Rep. 2024.
- Long-term risk of adjacent segment disease and construct design. Brain & Spine. 2025.